WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.

News Wanbangde Pharmaceutical Holding Group Co., Ltd.

Equities

002082

CNE000001P94

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-19 pm EDT			5-day change	1st Jan Change
5.08 ^CNY	-0.59%		-0.39%	-20.62%

May. 08	US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A	MT
Apr. 29	Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A	May. 08	MT
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Apr. 26	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Wanbangde Pharma Elects Vice Chairman, Appoints CFO	Jan. 29	MT
Wanbangde Pharma's Anesthesia Passes Drug Regulator's Consistency Evaluation	Jan. 19	MT
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) added to S&P Global BMI Index	23-09-18	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Board Appointments	23-07-31	CI
Wanbangde Pharmaceutical Registers New Medical Device	23-07-10	MT
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023	23-05-30	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-17	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Profit Distribution Proposal for 2022	23-04-26	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index	22-12-19	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma	22-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wanbangde Pharmaceutical Holding Group Co., Ltd.

Equities

002082

CNE000001P94

Summary

Filters